Dr. د عبدالوهاب حميدالدين

Professional Profile and Career Journey

Dr. Abdulwahab Hamidaddin is a distinguished authority in Hematology and Medical Oncology with over 15 years of dedicated clinical experience. Throughout his career, he has led multidisciplinary teams in diagnosing and treating complex blood disorders. His commitment to academic medicine and patient advocacy has positioned him as a leader at PulseHospital and the Eiadaty Health System, where he combines state-of-the-art diagnostic protocols with compassionate, patient-centered care strategies.

Areas of Subspecialty and Clinical Interests

Dr. Hamidaddin focuses on high-complexity hematological conditions, with a special emphasis on:
- Lymphomas (Hodgkin and Non-Hodgkin).
- Acute and Chronic Leukemias.
- Myelodysplastic Syndromes.
- Coagulation and Bleeding Disorders.
- Anemias of chronic disease and hematologic malignancies.

Procedures and Specialized Medical Interventions

Dr. Hamidaddin performs and oversees critical diagnostic and therapeutic procedures, including:
- Bone marrow aspiration and biopsy under local anesthesia.
- Comprehensive management of chemotherapy and targeted biological therapies.
- Immunotherapy administration tailored to individual genomic profiles.
- Coordination of autologous and allogeneic stem cell transplantation pathways.

Modern Diagnostic Technologies Used

Utilizing the latest advancements, Dr. Hamidaddin integrates the following into his clinical practice:
- Flow Cytometry for immunophenotyping.
- Molecular cytogenetic testing to identify oncogenic mutations.
- PET-CT fusion imaging for precise staging of lymphomas.
- Next-Generation Sequencing (NGS) for precision oncology.

Patient Guidelines: Before and After Treatment

Patients are advised to maintain a strict hygiene protocol and a nutrient-dense diet to support immune health. Dr. Hamidaddin emphasizes the importance of psychosocial support and maintaining a detailed log of symptoms and medication responses to optimize the treatment trajectory during intensive cycles.

Frequently Asked Questions (FAQ)

Q: Are all blood disorders malignant?
A: No. While my practice focuses on oncology, many blood disorders, such as iron deficiency anemia or specific clotting issues, are benign. Early diagnosis is key regardless of the nature of the condition.

Q: How does immunotherapy differ from traditional chemotherapy?
A: Immunotherapy helps your immune system fight cancer cells specifically, whereas chemotherapy targets rapidly dividing cells. We often use them in combination for better outcomes.

Q: How should I prepare for a bone marrow biopsy?
A: We ensure patients are comfortable through local anesthesia and sedation protocols. The procedure is brief, and post-procedure monitoring is provided to ensure safety.